St.Shine Optical Co.,Ltd. (1565.TWO)

TWD 199.5

(0.0%)

EBITDA Summary of St.Shine Optical Co.,Ltd.

  • St.Shine Optical Co.,Ltd.'s latest annual EBITDA in 2023 was 1.01 Billion TWD , down -37.71% from previous year.
  • St.Shine Optical Co.,Ltd.'s latest quarterly EBITDA in 2024 Q2 was 212.99 Million TWD , down -32.07% from previous quarter.
  • St.Shine Optical Co.,Ltd. reported an annual EBITDA of 1.62 Billion TWD in 2022, up 10.41% from previous year.
  • St.Shine Optical Co.,Ltd. reported an annual EBITDA of 1.48 Billion TWD in 2021, up 13.5% from previous year.
  • St.Shine Optical Co.,Ltd. reported a quarterly EBITDA of 212.99 Million TWD for 2024 Q2, down -32.07% from previous quarter.
  • St.Shine Optical Co.,Ltd. reported a quarterly EBITDA of 261.42 Million TWD for 2023 Q2, down -9.27% from previous quarter.

Annual EBITDA Chart of St.Shine Optical Co.,Ltd. (2023 - 2019)

Historical Annual EBITDA of St.Shine Optical Co.,Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 1.01 Billion TWD -37.71%
2022 1.62 Billion TWD 10.41%
2021 1.48 Billion TWD 13.5%
2020 1.28 Billion TWD -35.83%
2019 1.98 Billion TWD 0.0%

Peer EBITDA Comparison of St.Shine Optical Co.,Ltd.

Name EBITDA EBITDA Difference
Bioteque Corporation 736.13 Million TWD -37.344%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -760.076%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -1219.668%
BenQ Medical Technology Corporation 532.15 Million TWD -89.99%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD -50.05%
Unicon Optical Co., Ltd. 377.24 Million TWD -168.003%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 3.293%
Medeon Biodesign, Inc. -1.14 Billion TWD 188.538%
Concord Medical Co., Ltd. 137.47 Million TWD -635.439%
Crystalvue Medical Corporation 149.73 Million TWD -575.236%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -775.508%
ICARES Medicus, Inc. 165.54 Million TWD -510.747%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -799.787%
Amed Co., Ltd. 157.32 Million TWD -542.638%